We are a German biotech company
dedicated to the development of Lateral Flow Assays for point-of-care diagnosis, antibody-based treatments and reader software development.
dedicated to the development of Lateral Flow Assays for point-of-care diagnosis, antibody-based treatments and reader software development.
m-lab GmbH is a German biotech company, founded in 2014, with ties to some highly regarded research institutions, initially dedicated to the development of Lateral Flow Assays for POC diagnosis of eye diseases, including glaucoma, antibody-based treatments and reader software development, but we are presently expanding our research interests to include other targets and other pathologies.
Founder & Scientific Advisor
Head of R&D
Scientist
Bioinformatics & Software Development